SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-017199
Filing Date
2023-06-13
Accepted
2023-06-13 08:35:24
Documents
16
Period of Report
2023-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mbrx20230608_8k.htm   iXBRL 8-K 25619
2 EXHIBIT 99.1 ex_531366.htm EX-99.1 6904
7 logo.jpg GRAPHIC 5546
8 mbrx20230608_8kimg001.jpg GRAPHIC 3372
  Complete submission text file 0001437749-23-017199.txt   183830

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230613.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230613_def.xml EX-101.DEF 11533
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230613_lab.xml EX-101.LAB 15415
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230613_pre.xml EX-101.PRE 11689
10 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230608_8k_htm.xml XML 2562
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 231010289
SIC: 2834 Pharmaceutical Preparations